Liver disease is one of the most overlooked secondary VA disability claims — and one of the most stigmatized. Veterans whose PTSD, MST, or combat trauma led to alcohol use disorder (AUD), whose wartime service exposed them to hepatitis C, or whose service-connected pain conditions required years of liver-taxing medications may have a strong secondary claim for hepatitis, cirrhosis, or other liver conditions. This guide explains the three main pathways, the VA diagnostic codes that apply, how liver disease is rated, and the nexus strategy that gets claims approved.
Under 38 CFR §3.310, a condition that is proximately due to or the result of a service-connected disease or injury can itself be service-connected as a secondary disability. For liver disease, the three most clinically well-established secondary pathways are:
The VA explicitly permits multi-link chains: PTSD → AUD → liver disease. Each link must be established with medical evidence, but you do not need a direct service connection for the liver — only for the condition that started the chain. See our secondary service connection guide for the full regulatory framework.
This is the most important and most misunderstood pathway for liver disease claims. Many veterans with PTSD — particularly combat veterans, survivors of MST, and those exposed to traumatic military events — turned to alcohol as a coping mechanism. Chronic heavy alcohol use is the leading cause of alcoholic liver disease, alcoholic hepatitis, and liver cirrhosis in the United States.
The legal and medical framework for this chain is well-established:
Each link must be supported by at least one medical opinion meeting the "at least as likely as not" standard. A strong nexus letter from a hepatologist who reviews your full treatment history — including PTSD records — can tie all three links together in a single document.
Veterans who experienced Military Sexual Trauma (MST) often develop PTSD, depression, and substance use disorders as a direct result. The same chain — MST/PTSD → AUD → liver disease — is legally and medically sound. The VA is required to give MST-related claims liberal consideration under 38 CFR §3.304(f)(5), and the lower evidentiary threshold for MST claims extends to secondary conditions flowing from the MST-related mental health disorder.
Moral injury — the psychological damage caused by participating in, witnessing, or failing to prevent acts that violate one's moral code — is increasingly recognized in veterans' mental health literature as a driver of alcohol misuse. Veterans who struggle with moral injury often don't fit a clean PTSD diagnosis but still develop substance use disorders. If your mental health records document moral injury, substance use, and liver disease, a knowledgeable physician can still construct the causal chain under the broader framework of "mental health condition secondary to service."
The PTSD→AUD→liver disease chain is one of the most underused secondary claims in VA benefits. Get free help building your evidence chain today.
Start Your Free Secondary Claim Review →Hepatitis C is a blood-borne viral infection that causes chronic liver inflammation, fibrosis, cirrhosis, and — in some cases — hepatocellular carcinoma (liver cancer). The VA recognizes several specific military exposure pathways for HCV that predate modern infection control standards:
To establish direct service connection for hepatitis C (rather than secondary service connection), you need to: (1) document the specific in-service exposure event, (2) show a current HCV diagnosis, and (3) have a nexus letter connecting the two. The VA's M21-1 Adjudication Manual specifically lists jet-gun injection as a qualifying HCV exposure event.
If you served between 1965 and 1992 and have HCV, your service records or buddy statements documenting participation in mass vaccination events using jet injectors can be critical evidence. Request your service treatment records (STRs) from the National Personnel Records Center and look for documentation of immunization events. Even without documentation, a personal statement describing the jet-gun vaccination process may be sufficient given how widespread the practice was.
Chronic hepatitis C is one of the leading causes of hepatocellular carcinoma (HCC). Veterans who develop liver cancer secondary to service-connected HCV are entitled to a 100% schedular rating for the active malignancy under DC 7343, plus SMC consideration for the functional limitations associated with cancer treatment. If you have both HCV and HCC, file both conditions — the cancer as secondary to the HCV.
Drug-induced liver injury (DILI) is the most common cause of acute liver failure in the United States, and it is a real but underappreciated risk for veterans who take certain medications long-term to manage service-connected conditions. Two categories of drugs are particularly relevant:
Non-steroidal anti-inflammatory drugs — ibuprofen (Advil/Motrin), naproxen (Aleve/Naprosyn), diclofenac, celecoxib, and ketorolac (Toradol) — are the most commonly prescribed medications for service-connected musculoskeletal pain. While the kidneys bear the primary brunt of chronic NSAID use, the liver processes these drugs as well, and high-dose or long-term use — particularly combined with alcohol — can cause hepatotoxicity. Veterans with service-connected back pain, knee osteoarthritis, or other pain conditions who have been on NSAIDs for years and have developed elevated liver enzymes or DILI have a viable secondary claim pathway.
Statins (atorvastatin, simvastatin, rosuvastatin, lovastatin) are commonly prescribed to veterans with service-connected cardiovascular disease, hypertension, or diabetes to manage cholesterol. Statin-induced liver injury — ranging from transient enzyme elevation to, rarely, more serious liver disease — is a recognized side effect. If your VA provider prescribed statins for a service-connected cardiovascular condition and you subsequently developed liver disease, a hepatologist or internist can evaluate the causal relationship.
The key principle for medication-related liver claims is the same as for NSAID kidney claims: if the medication was prescribed to manage a service-connected condition, and the medication caused organ damage, the organ damage can be claimed as secondary to the service-connected condition that necessitated the medication.
The VA rates liver conditions under 38 CFR Part 4, §4.114, using Diagnostic Codes 7312 through 7354. The key codes for the conditions most relevant to veterans are:
| Diagnostic Code | Condition |
|---|---|
| DC 7312 | Liver cirrhosis, primary biliary — rated under §4.114 |
| DC 7313 | Liver abscess |
| DC 7314 | Liver — toxic hepatitis (including DILI from medications) |
| DC 7318 | Liver — cholecystitis, chronic |
| DC 7343 | Malignant neoplasms of the digestive system (liver cancer — 100% while active) |
| DC 7345 | Chronic liver disease without cirrhosis (includes chronic hepatitis) |
| DC 7351 | Liver transplant — 100% for 1 year post-surgery, then rated on residuals |
| DC 7354 | Hepatitis C (chronic) — rated under the general formula for liver conditions |
Most veterans with PTSD-related alcoholic liver disease will be rated under DC 7312 (cirrhosis) or DC 7345 (chronic liver disease without cirrhosis). Veterans with service-connected hepatitis C will be rated under DC 7354, which references the general liver rating formula below.
The VA rates liver conditions under a general formula based on signs and symptoms of liver dysfunction, including fatigue, malaise, nausea, anorexia, weight loss, jaundice, ascites, and laboratory values (liver enzymes, bilirubin, albumin, prothrombin time). The rating levels under the general liver disease formula are:
| Rating | Criteria |
|---|---|
| 100% | Near-constant debilitating symptoms (daily fatigue, malaise, anorexia, with cirrhosis and hepatic encephalopathy or hepatorenal syndrome); OR requiring liver transplant (100% for 1 year post-transplant) |
| 70% | Frequent episodes of fatigue, malaise, nausea, anorexia, and weight loss with liver function test (LFT) abnormalities and cirrhosis or other progressive liver disease |
| 40% | Intermittent episodes of fatigue, malaise, nausea, anorexia, and weight loss with LFT abnormalities, or with liver biopsy showing significant fibrosis (Stage 2–3) |
| 20% | Intermittent symptoms (fatigue, malaise, nausea) with or without minor LFT elevations |
| 10% | Symptoms controlled with diet or medication; minor LFT abnormalities |
| 0% | Asymptomatic; diagnosis only; normal or near-normal LFTs |
The Child-Pugh classification is the clinical standard for assessing cirrhosis severity. It scores five factors: bilirubin, albumin, prothrombin time (INR), ascites, and hepatic encephalopathy. Child-Pugh scores map roughly onto VA rating levels:
| Child-Pugh Class | Score | 1-Year Survival | Typical VA Rating Range |
|---|---|---|---|
| Class A (compensated) | 5–6 | ~100% | 20–40% |
| Class B (moderate) | 7–9 | ~80% | 40–70% |
| Class C (decompensated) | 10–15 | ~45% | 70–100% |
When presenting your claim, having your hepatologist document both the Child-Pugh score and its clinical implications (ascites requiring paracentesis, varices, encephalopathy episodes) gives the VA rater concrete clinical data to support a higher rating.
Veterans with decompensated cirrhosis — defined by the presence of ascites, hepatic encephalopathy, variceal bleeding, or spontaneous bacterial peritonitis — should be rated at 70% or 100%. If the VA rates you lower despite these documented complications, file for a rating increase immediately and consider working with a VA-accredited attorney to appeal.
Many veterans — and unfortunately some C&P examiners and VA raters — still harbor the assumption that liver disease caused by alcohol use is a matter of personal choice rather than a recognized medical consequence of a service-connected mental health condition. This stigma can result in lower ratings, unfavorable nexus opinions, or outright denials. Here's how to preemptively address it:
Your nexus letter should be written in medical, clinical language that frames AUD as a condition — not a choice. The American Medical Association, the DSM-5, and the VA itself classify AUD as a diagnosable medical disorder. Your nexus letter should explicitly state: "Alcohol use disorder is a recognized psychiatric condition under DSM-5 criteria and is clinically documented as a common sequela of PTSD. The veteran's AUD represents a medical complication of the service-connected PTSD, not a willful misconduct."
The VA's willful misconduct bar (38 CFR §3.301) can potentially be raised for disabilities caused by "abuse of alcohol" — but the BVA and the U.S. Court of Appeals for Veterans Claims (CAVC) have consistently held that AUD secondary to PTSD does not constitute willful misconduct because the alcohol use was driven by a service-connected mental health condition, not by pure volition. The key case here is Allen v. Principi (2001, Fed. Cir.), which established that substance use disorders secondary to service-connected PTSD can be service-connected.
A strong claim demonstrates that PTSD symptoms and diagnosis predate the onset of heavy alcohol use, which in turn predates the liver disease. If your service records, VA mental health records, and gastroenterology records together show this timeline, the causal chain is apparent. Ask your treating providers to explicitly document this sequence in your records and nexus letter.
Liver disease secondary claims often require nexus letters from two providers: a mental health provider (psychiatrist or psychologist) addressing the PTSD→AUD link, and a hepatologist or gastroenterologist addressing the AUD→liver disease link. In some cases a single physician with sufficient expertise in both areas can write a combined letter, but more commonly two targeted letters are more persuasive.
Your psychiatrist or VA mental health provider should state:
Your hepatologist or gastroenterologist should state:
Related guides: Secondary Service Connection Guide, VA Disability Rating for PTSD, Alcohol Use Disorder Secondary to PTSD, and Kidney Disease Secondary VA Claim.
Editorial Standards: This article was written by Marcus J. Webb, a veterans benefits researcher who has studied 38 CFR Part 4, the VA M21-1 Adjudication Manual, and thousands of BVA decisions. Content is verified against current 38 CFR regulations and VA.gov guidance. Last reviewed: April 2026. Not legal advice — for representation on your specific claim, talk to a VA-accredited attorney.